Zacks Investment Research on MSN
UiPath (PATH) stock sinks as market gains: Here's why
UiPath (PATH) closed at $14.79 in the latest trading session, marking a -3.77% move from the prior day. This change lagged the S&P 500's daily gain of 0.26%. Elsewhere, the Dow gained 0.6%, while the ...
We recently published 10 Stocks Sparking Massive Fortunes. UiPath Inc. (NYSE:PATH) is one of the best performers on Friday. UiPath soared 34.7 percent week-on-week to hit a 19-month high, as investors ...
Zacks Investment Research on MSN
UiPath (PATH) is a great momentum stock: Should you buy?
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long ...
UiPath's stock has dropped ~20% since January, presenting a buying opportunity for long-term investors, despite macroeconomic concerns and disappointing Q4 results. UiPath focuses on agentic ...
Revenue problems and a CEO resignation led to a drop in share price, but UiPath is still growing at decent rates and cash-flow positive. Technology advancements like process mining and task log ...
UiPath launches AI-based Medical Record Summarization tool, reducing processing time from 45 minutes to minutes. Powered by Google Cloud, the agent improves accuracy, saves 40 minutes per referral, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results